ProCE Banner Activity

Sequencing HER2+ Metastatic Breast Cancer Care Beyond Second-line Therapy

Slideset

Download this slideset by experts with the latest evidence for sequencing treatment for HER2+ metastatic breast cancer beyond the second line.

Released: March 04, 2025

Expiration: March 03, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.